Full article at my site #HealthNews #FDA #PatientSafety #HeartHealth #Pharmacy To view or add a comment, sign in FDA accepts license application for a treatment of generalised pustular psoriasis The US Food and Drug Administration (FDA) has accepted the filing of a Biologics License Application (BLA) for imsidolimab for the treatment of generalised pustular psoriasis (GPP), with a target action date of 12 December 2026
For those interested in combining cagrilintide with tirzepatide instead, the dosing considerations become more complex since that represents an off-label combination
By nourishing your body with the right foods, managing stress, and supporting glutathione production naturally or through supplements, you can promote healthier hair growth and restore your scalp's vitality
Some people taking gabapentin report weight gain, although this does not happen to everyone
How Tesamorelin Targets Visceral Fat Tesamorelin is most interesting because of its effect on visceral adipose tissue, the deeper abdominal fat stored around internal organs